Cryoablation for Fibroadenomas & Breast Cancer

1 August 2016 Some patients with benign breast fibroadenomas are candidates for a non-surgical therapy called cryoablation. This involves freezing the benign lump within the breast, and the mass reabsorbs without the need for surgical removal. The in-office procedure is performed under local anesthesia, and usually takes about 15 minutes. Ideal candidates are patients who have fibroadenomas less than 2cm in…

Read more

ASBrS Issues CPM Consensus Statment

During the April 2016 meeting of the American Society of Breast Surgeons (ASBrS), a consensus conference was held to discuss contralateral prophylactic mastectomy (CPM). CPM is the removal of the healthy, opposite breast, and the rates of CPM have been increasing, for various reasons. A patient’s decision to undergo a CPM is very difficult and is unique to each individual with breast cancer.…

Read more

Choosing Wisely

27 June 2016 Choosing Wisely is an initiative of the American Board of Internal Medicine Foundation. Things Providers and Patients Should Question have been chosen by various medical societies based on review of the evidence-based literature. The American Society of Breast Surgeons (ASBrS) has published their contributions to the campaign (open access) in the Annals of Surgical Oncology. The 5 ASBrS measures include: 1.) Don’t…

Read more

Importance of Treatment Follow Up

23 June 2016 Many patients realize that follow up appointments with their treating doctors is a routine part of cancer care. However, I am occasionally asked by patients why they need to continue seeing me or their oncologist after treatment has ended. A recently published study demonstrates that many patients do not understand why follow up care is important. Dr. Annette…

Read more

What Do Patients Prefer?

21 June 2016 Originally posted on the BCSM.org website In October, we solicited input a research survey designed to identify how patients prefer to be notified of a new cancer diagnosis and cancer-related test results. The results were presented at the 2016 Annual Meeting of the American Society of Breast Surgeons in April. The full manuscript – What Do Patients Prefer? Understanding…

Read more

Extended Hormone Therapy for Postmenopausal Breast Cancer

09 June 2016 A study presented at the recent American Society of Clinical Oncology meeting evaluated the use of extended endocrine therapy in post-menopausal women. I’ve covered some of the basics of endocrine therapy for breast cancer in a previous post. In 2012, results of the ATLAS Trial were published, and found that when tamoxifen was given for 10 years instead of the standard…

Read more

Reflections on An Incredible Year

On April 15, 2016, I passed the gavel of the American Society of Breast Surgeons (ASBrS) to our new President, Dr. Sheldon Feldman. The weeks leading up to the meeting were filled with anticipation, anxiety, and a few nightmares. I had dreams that I slept through my Presidential Address, and that I forgot to prepare my slides. My nightmares stopped…

Read more

Is Dense Breast Notification Too Dense?

26 April 2016 A growing number of states have enacted so-called “dense breast” legislation – requirements that radiology facilities inform patients if they have dense breast tissue, which may limit the sensitivity of mammography. A study published in the Journal of the American Medical Association evaluated the dense breast legislation for 23 states who have these requirements. They evaluated the…

Read more

Media Reporting on Celebrity Breast Cancer

20 April 2016 I’ve written about the “celebrity effect” before –  misinformation disseminated by public features that subsequently influences patient decision making. A new study published in the Annals of Surgical Oncology notes that the celebrity effect extends to media coverage as well. The authors evaluated media coverage of celebrity breast cancer stories. They found that since 2004, celebrity breast…

Read more

Lifestyle Behaviors Among US Cancer Survivors

28 January 2016 Due to improvements in diagnosis and treatment, patients who have undergone cancer therapy are living longer than ever. The American Cancer Society estimates that there are approximately 15.5 million people living in the United States who have been treated for cancer, and that number is likely to increase. Cancer survivors not only cope with the normal effects of…

Read more
Pages